- Home
- FBIOP vs WGS Comparison
FBIOP vs WGS Comparison
Compare FBIOP & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- WGS
- Stock Information
- Founded
- FBIOP N/A
- WGS 2017
- Country
- FBIOP United States
- WGS United States
- Employees
- FBIOP 101
- WGS N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- FBIOP Health Care
- WGS Technology
- Exchange
- FBIOP Nasdaq
- WGS Nasdaq
- Market Cap
- FBIOP N/A
- WGS N/A
- IPO Year
- FBIOP N/A
- WGS N/A
- Fundamental
- Price
- FBIOP $8.41
- WGS $84.13
- Analyst Decision
- FBIOP
- WGS Strong Buy
- Analyst Count
- FBIOP 0
- WGS 8
- Target Price
- FBIOP N/A
- WGS $89.13
- AVG Volume (30 Days)
- FBIOP N/A
- WGS 982.7K
- Earning Date
- FBIOP N/A
- WGS 07-29-2025
- Dividend Yield
- FBIOP N/A
- WGS N/A
- EPS Growth
- FBIOP N/A
- WGS N/A
- EPS
- FBIOP N/A
- WGS N/A
- Revenue
- FBIOP N/A
- WGS $330,143,000.00
- Revenue This Year
- FBIOP N/A
- WGS $21.92
- Revenue Next Year
- FBIOP N/A
- WGS $18.74
- P/E Ratio
- FBIOP N/A
- WGS N/A
- Revenue Growth
- FBIOP N/A
- WGS 48.81
- 52 Week Low
- FBIOP N/A
- WGS $25.32
- 52 Week High
- FBIOP N/A
- WGS $117.75
- Technical
- Relative Strength Index (RSI)
- FBIOP 56.06
- WGS 52.78
- Support Level
- FBIOP $7.82
- WGS $82.12
- Resistance Level
- FBIOP $8.60
- WGS $93.55
- Average True Range (ATR)
- FBIOP 0.45
- WGS 6.26
- MACD
- FBIOP -0.01
- WGS -0.09
- Stochastic Oscillator
- FBIOP 80.73
- WGS 63.33
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.